Catheterization and Cardiovascular Interventions最新文献

筛选
英文 中文
Intravascular Ultrasound Assessment of Distal Trans-Radial Access in Patients Undergoing Percutaneous Coronary Intervention. 血管内超声评估经皮冠状动脉介入治疗患者的远端经导管入路情况。
IF 2.1 3区 医学
Catheterization and Cardiovascular Interventions Pub Date : 2024-10-29 DOI: 10.1002/ccd.31279
Enrico Poletti, Giuseppe Colletti, Carlo Zivelonghi, Alice Benedetti, Alice Moroni, Hicham El Jattari, Alexandre Natalis, Francesca Rubino, Benjamin Scott, Elias Bentakhou, Steven E F Haine, Pierfrancesco Agostoni, Claudiu Ungureanu
{"title":"Intravascular Ultrasound Assessment of Distal Trans-Radial Access in Patients Undergoing Percutaneous Coronary Intervention.","authors":"Enrico Poletti, Giuseppe Colletti, Carlo Zivelonghi, Alice Benedetti, Alice Moroni, Hicham El Jattari, Alexandre Natalis, Francesca Rubino, Benjamin Scott, Elias Bentakhou, Steven E F Haine, Pierfrancesco Agostoni, Claudiu Ungureanu","doi":"10.1002/ccd.31279","DOIUrl":"https://doi.org/10.1002/ccd.31279","url":null,"abstract":"<p><strong>Background: </strong>Distal trans-radial access (dTRA) for percutaneous coronary interventions (PCI) is increasingly gaining attention due to its potential to mitigate radial artery occlusion (RAO). However, a comprehensive understanding of the mechanical impact of the devices on the radial artery (RA) wall remains limited. Using a complete intravascular ultrasound (IVUS) evaluation of the RA, including also the vascular access site, we aimed to evaluate all the consequences related to the catheterization on the RA wall, starting from the vascular access, comparing conventional sheath and sheathless approaches.</p><p><strong>Methods: </strong>This is an observational, prospective, multicenter study aimed to assess the entire RA wall immediately after IVUS-guided PCI via-dTRA. IVUS assessment included quantitative measurements (minimal lumen area [MLA], minimal vessel area [MVA]) and qualitative observations (dissections, vasospasm). Study objectives included delineating RA wall structure post-PCI and comparing findings between conventional and sheathless approaches.</p><p><strong>Results: </strong>Fifty patients (21 [42%] with conventional sheath, 29 [58%] sheathless) were enrolled between March 2023 and February 2024. Female patients were more prevalent in the convention sheath group (38% vs. 7%, p < 0.001). Sheathless approach utilized 7-French guiding catheters more frequently (33% vs. 86%, p < 0.001). Post-procedural IVUS identified dissections in 12% of cases, with no significant difference between approaches. Arterial vasospasm was present in a quarter of patients, numerically higher in the conventional sheath group (29% vs. 21%, p = 0.5). MLA and MVA were comparable between groups, though MLA and MVA were lowest at the proximal segment of the RA only in the conventional sheath group (p < 0.001). No RAO was documented during the IVUS evaluation.</p><p><strong>Conclusions: </strong>The intravascular assessment of dTRA after coronary interventions, utilizing either conventional or sheathless approaches, including large-bore guiding catheters, demonstrated a relatively low incidence of access-related complications such as dissection and vasospasm, without affecting the flow and patency of the proximal RA.</p>","PeriodicalId":9650,"journal":{"name":"Catheterization and Cardiovascular Interventions","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142521124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interventional Applications for an Ostial Protection Guidewire-The WALPO Technique. 骨膜保护导丝的介入应用--WALPO 技术。
IF 2.1 3区 医学
Catheterization and Cardiovascular Interventions Pub Date : 2024-10-28 DOI: 10.1002/ccd.31274
Gregor Leibundgut, Mihajlo Kovacic, Mihai Cocoi, Stephane Rinfret
{"title":"Interventional Applications for an Ostial Protection Guidewire-The WALPO Technique.","authors":"Gregor Leibundgut, Mihajlo Kovacic, Mihai Cocoi, Stephane Rinfret","doi":"10.1002/ccd.31274","DOIUrl":"https://doi.org/10.1002/ccd.31274","url":null,"abstract":"<p><p>Coronary atherosclerotic lesions at the ostium and proximal coronary arteries pose significant challenges in percutaneous coronary interventions (PCI), especially in the left main coronary artery (LMCA). Guide catheter-induced damage can lead to severe complications such as vessel dissection or myocardial infarction. Ostial stent placement with drug-eluting stents offers mechanical support and reduces restenosis but is technically challenging due to the anatomical complexity of the ostium. Complications like longitudinal stent deformation and hydraulic dissection from contrast media are specific concerns. The aortic free-floating wire technique, expanded in this article to Wire in Aorta for Localization and Protection of the Ostium (WALPO), provides a method for safely locating and protecting the ostium during PCI, aiming to improve the safety and efficacy of PCI at this location.</p>","PeriodicalId":9650,"journal":{"name":"Catheterization and Cardiovascular Interventions","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142495764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug-coated balloons in high-risk patients and diabetes mellitus: A meta-analysis of 10 studies. 高危患者和糖尿病患者的药物涂层球囊:10 项研究的荟萃分析。
IF 2.1 3区 医学
Catheterization and Cardiovascular Interventions Pub Date : 2024-10-28 DOI: 10.1002/ccd.31257
Monica Verdoia, Matteo Nardin, Andrea Rognoni, Bernardo Cortese
{"title":"Drug-coated balloons in high-risk patients and diabetes mellitus: A meta-analysis of 10 studies.","authors":"Monica Verdoia, Matteo Nardin, Andrea Rognoni, Bernardo Cortese","doi":"10.1002/ccd.31257","DOIUrl":"https://doi.org/10.1002/ccd.31257","url":null,"abstract":"<p><strong>Background: </strong>Despite the improvements in drug eluting stents (DES) technology, suboptimal results have been observed in certain higher-risk subsets of patients, as in diabetes mellitus (DM). Drug-coated balloons (DCB) could represent an alternative to DES in complex populations and anatomies, as in DM.</p><p><strong>Aims: </strong>The present meta-analysis aimed at assessing the role of DCBs in patients with diabetes mellitus.</p><p><strong>Methods: </strong>Studies comparing DCB versus percutaneous coronary revascularization (PCI) with/without DES for PCI in high-risk populations (>30% DM) were included. The primary efficacy endpoint was overall mortality, secondary endpoints were myocardial infarction, target lesion revascularization (TLR), and major adverse cardiovascular events (MACE).</p><p><strong>Results: </strong>We included 10 studies, comprising 2026 patients. Among them, 1002 patients (49.5%) were treated with DCB and 1024 with DES implantation. Among the included studies, 6 only enrolled diabetic patients and 2 had a prevalence of diabetes of 50%. At a mean follow-up of 15.3 months, mortality rate was 3.8% (82 patients), significantly lower with DCB (3.2% vs. 4.9% with DES; odds ratio [OR] [95% confidence interval {CI}] = 0.61 [0.38, 0.97], p = 0.04 p<sub>het</sub> = 0.34. A similar reduction in favor of DCB was observed for MACE (13.6% vs. 17.6%; OR [95% CI] = 0.79 [0.61, 1.04], p = 0.09, p<sub>het</sub> = 0.25), while TLR was significantly reduced only in the diabetic-restricted sub-analysis.</p><p><strong>Conclusion: </strong>In the present meta-analysis, we showed a significant survival benefit and an absolute reduction in MACE and TLR with a DCB-based strategy as compared to DES in high-risk patients, mostly with DM. Future large-scale randomized trials, dedicated to this population, are deserved to confirm our findings.</p><p><strong>What is known: </strong>Complex coronary anatomies and diabetes mellitus (DM) represent the pitfall of drug eluting stents (DES), mainly due to inflammatory and thrombotic complications, which should be reduced with drug-coated balloons (DCB).</p><p><strong>What is new: </strong>We confirmed a significant advantage of DCB versus DES in the treatment of de novo lesions in high-risk patients and mainly in DM, reducing overall mortality, MACE and target lesion revascularization.</p>","PeriodicalId":9650,"journal":{"name":"Catheterization and Cardiovascular Interventions","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142495763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The feasibility of double stent strategy in left main true bifurcation with small and large angle change between diastole and systole: The Milan and New-Tokyo (MITO) registry. 舒张期和收缩期角度变化小和大的左主干真分叉双支架策略的可行性:米兰和新东京(MITO)登记。
IF 2.1 3区 医学
Catheterization and Cardiovascular Interventions Pub Date : 2024-10-27 DOI: 10.1002/ccd.31240
Yusuke Watanabe, Toru Naganuma, Alaide Chieffo, Matteo Montorfano, Masaaki Okutsu, Satoko Tahara, Koji Hozawa, Sunao Nakamura, Antonio Colombo
{"title":"The feasibility of double stent strategy in left main true bifurcation with small and large angle change between diastole and systole: The Milan and New-Tokyo (MITO) registry.","authors":"Yusuke Watanabe, Toru Naganuma, Alaide Chieffo, Matteo Montorfano, Masaaki Okutsu, Satoko Tahara, Koji Hozawa, Sunao Nakamura, Antonio Colombo","doi":"10.1002/ccd.31240","DOIUrl":"https://doi.org/10.1002/ccd.31240","url":null,"abstract":"<p><strong>Background: </strong>Provisional single stenting strategy (PSS) is a default strategy for percutaneous coronary intervention (PCI) of unprotected left main distal bifurcation lesions (ULMD). Previous study reported that a bifurcation angle change (BAC) between end diastole and systole was associated with outcomes after PCI with double stent strategy (DSS) for ULMD. However, there are no data comparing outcomes after PCI with PSS versus DSS according the degree of BAC.</p><p><strong>Objectives: </strong>We evaluated outcomes after PCI with PSS versus DSS for true ULMD with small and large BAC.</p><p><strong>Methods: </strong>We identified 566 patients with true ULMD underwent PCI in three high-volume centers. We calculated the BAC in ULMD between end-diastole and systole before stenting with 2-dimensional quantitative coronary angiographic assessment. We defined small (BAC < 7.0°) and large BAC (≥7.0°) group. We compared clinical outcomes after PCI with PSS versus DSS in each cohort after propensity score adjustment. The primary endpoint was target-lesion failure (TLF), which was defined as a composite of cardiac death, target lesion revascularization, and myocardial infarction.</p><p><strong>Results: </strong>In small BAC cohort, TLF rate was significantly lower in DSS group than in PSS group (12.5% vs. 20.1%, adjusted HR 0.45; 95% CI, 0.26-0.79; p = 0.006). In contrast, in large BAC cohort, TLF rate was significantly higher in DSS group than in PSS group (54.9% vs. 29.0%, adjusted HR 2.25; 95% CI, 1.50-3.38; p < 0.001).</p><p><strong>Conclusions: </strong>The TLF rate after PCI with DSS was significantly lower in true ULMD with small BAC compared to PSS even after propensity score adjustment. In contrast, it was significantly higher in those with large BAC.</p>","PeriodicalId":9650,"journal":{"name":"Catheterization and Cardiovascular Interventions","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142495767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous endovascular management of Angio-Seal related vascular occlusion. 经皮血管内治疗 Angio-Seal 相关血管闭塞。
IF 2.1 3区 医学
Catheterization and Cardiovascular Interventions Pub Date : 2024-10-27 DOI: 10.1002/ccd.31272
Dan Haberman, Evan Czulada, Lior Lupu, Kalyan R Chitturi, Abhishek Chaturvedi, Waiel Abusnina, Ilan Merdler, Pavan Reddy, Itsik Ben-Dor, Lowell F Satler, Ron Waksman, Nelson L Bernardo
{"title":"Percutaneous endovascular management of Angio-Seal related vascular occlusion.","authors":"Dan Haberman, Evan Czulada, Lior Lupu, Kalyan R Chitturi, Abhishek Chaturvedi, Waiel Abusnina, Ilan Merdler, Pavan Reddy, Itsik Ben-Dor, Lowell F Satler, Ron Waksman, Nelson L Bernardo","doi":"10.1002/ccd.31272","DOIUrl":"https://doi.org/10.1002/ccd.31272","url":null,"abstract":"<p><strong>Background: </strong>The use of vascular closure devices (VCDs) to achieve quick and safe hemostasis after femoral arterial access is widely accepted. Major complications include bleeding and occlusion of the femoral artery due to device failure, which often necessitates vascular intervention. This manuscript details our peripheral percutaneous endovascular interventional (PEI) approach for the management of femoral artery occlusion resulting from Angio-Seal (Terumo, Somerset, New Jersey, USA) VCD deployment.</p><p><strong>Methods: </strong>Consecutive patients who developed occlusive complications after Angio-Seal deployment underwent PEI to overcome specific complications. Patients' clinical and procedural characteristics, along with their short- and long-term follow-up data, were analyzed.</p><p><strong>Results: </strong>The study cohort included 40 patients who experienced Angio-Seal occlusive complications between July 2013 and September 2023. The mean age of the patients was 74 ± 10 years and 55% were female. All the patients were treated with PEI, with an overall procedural success rate of 100%. The primary approach for PEI was directional atherectomy, which was used in 35 cases (88%), followed by balloon, while a cutting balloon was used in 5 patients (13%). Stenting served as the definitive therapy in only 7 patients (18%). No procedural complications or conversions to surgery were observed. During a median follow-up of 244 (IQR = 100-707) days, none of the patients required re-intervention related to Angio-Seal occlusion and salvage intervention.</p><p><strong>Conclusion: </strong>In the management of Angi-Seal VCD-related femoral artery occlusion, the adjunctive use of directional atherectomy followed by balloon angioplasty was effective and safe, allowing re-establishment of flow with excellent long-term outcomes.</p>","PeriodicalId":9650,"journal":{"name":"Catheterization and Cardiovascular Interventions","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142495765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rotational, orbital atherectomy and intravascular lithotripsy for coronary calcified nodules: insights from optical coherence tomography. 针对冠状动脉钙化结节的旋转式、轨道式动脉粥样硬化切除术和血管内碎石术:光学相干断层扫描的启示。
IF 2.1 3区 医学
Catheterization and Cardiovascular Interventions Pub Date : 2024-10-23 DOI: 10.1002/ccd.31246
Keisuke Yasumura, Anoop N Koshy, Manish Vinayak, Yuliya Vengrenyuk, Shingo Minatoguchi, Parasuram Krishnamoorthy, Amit Hooda, Raman Sharma, Vishal Kapur, Joseph Sweeny, Samin K Sharma, Annapoorna S Kini
{"title":"Rotational, orbital atherectomy and intravascular lithotripsy for coronary calcified nodules: insights from optical coherence tomography.","authors":"Keisuke Yasumura, Anoop N Koshy, Manish Vinayak, Yuliya Vengrenyuk, Shingo Minatoguchi, Parasuram Krishnamoorthy, Amit Hooda, Raman Sharma, Vishal Kapur, Joseph Sweeny, Samin K Sharma, Annapoorna S Kini","doi":"10.1002/ccd.31246","DOIUrl":"https://doi.org/10.1002/ccd.31246","url":null,"abstract":"<p><strong>Background: </strong>The optimal treatment strategy for coronary calcified nodules (CN) remains uncertain. We aimed to evaluate the efficacy and safety of different calcium modification strategies, including rotational atherectomy (RA), orbital atherectomy (OA), and intravascular lithotripsy (IVL) for managing CN with optical coherence tomography (OCT) guidance.</p><p><strong>Methods: </strong>Consecutive patients undergoing OCT-guided percutaneous coronary intervention (PCI) for severely calcified lesions using RA, OA, or IVL between January 2017 and December 2022 were included. Primary endpoint was minimum stent area (MSA) post-PCI. Secondary endpoints included MSA at CN site and 1-year target vessel failure (TVF), defined as a composite of cardiac death, target-vessel myocardial infarction, or target vessel revascularization.</p><p><strong>Results: </strong>Among 154 patients and 158 lesions, CN was identified in 54 lesions (34.2%) and managed with RA (39%, n = 21), OA (33%, n = 18), or IVL (28%, n = 15). The IVL group exhibited a larger minimal lumen diameter, maximum calcium arc, and maximum calcium thickness. Post-PCI OCT demonstrated comparable MSA (RA: 6.23 ± 0.34 mm², OA: 5.75 ± 0.39 mm², IVL: 6.24 ± 0.46 mm²; p = 0.62) and MSA at CN site (7.17 ± 0.43 mm², 6.46 ± 0.49 mm², 7.86 ± 0.56 mm², respectively; p = 0.55) after adjusting for morphologic factors. The incidence of TVF at 1 year was similar among the group (RA: 19.0%, OA: 22.2%, IVL: 13.3%, p = 0.81).</p><p><strong>Conclusions: </strong>In patients undergoing PCI for CN, similar procedural and clinical outcomes can be achieved using RA, OA, or IVL. These findings warrant further investigation in larger, prospective trials.</p>","PeriodicalId":9650,"journal":{"name":"Catheterization and Cardiovascular Interventions","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142495766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SAICR-CTO: Single Access Impella-Guided Complete Revascularization in Chronic Total Occlusion-A Novel Approach to High-Risk PCI. SAICR-CTO:单通道Impella引导的慢性全闭塞完全血管再通--高风险PCI的新方法。
IF 2.1 3区 医学
Catheterization and Cardiovascular Interventions Pub Date : 2024-10-22 DOI: 10.1002/ccd.31277
Vaibhav Sharma, Abishek Arokiadoss, Anjali Bhardwaj, Shariq Shamim
{"title":"SAICR-CTO: Single Access Impella-Guided Complete Revascularization in Chronic Total Occlusion-A Novel Approach to High-Risk PCI.","authors":"Vaibhav Sharma, Abishek Arokiadoss, Anjali Bhardwaj, Shariq Shamim","doi":"10.1002/ccd.31277","DOIUrl":"https://doi.org/10.1002/ccd.31277","url":null,"abstract":"<p><p>The Impella is a ventricular assist device (VAD) that provides circulatory assistance to patients with impaired heart function during percutaneous coronary intervention (PCI). It ejects blood from the left ventricle directly into the aorta. Although most cases of Impella-assisted PCI are done using two access ports, the single access technique was described by Jason Wollmuth et al. An inherent drawback of multiple access is the heightened susceptibility to vascular complications like thrombosis, hematoma, pseudoaneurysm, and retroperitoneal bleeding. Single access for high-risk PCI (SHiP) reduces complications from PCI access and is useful in patients with limited arterial access. This study presents a case of extension of SHiP technique used in a case of complex high-risk intervention and CTO with dual access using an Impella single-access sheath.</p>","PeriodicalId":9650,"journal":{"name":"Catheterization and Cardiovascular Interventions","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142458780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heart Failure Hospitalization Preceding Transcatheter Aortic Valve Implantation as a Prognostic Marker. 经导管主动脉瓣植入术前的心力衰竭住院治疗是预后标志。
IF 2.1 3区 医学
Catheterization and Cardiovascular Interventions Pub Date : 2024-10-22 DOI: 10.1002/ccd.31275
Pernille Steen Bække, Ole De Backer, Troels Højsgaard Jørgensen
{"title":"Heart Failure Hospitalization Preceding Transcatheter Aortic Valve Implantation as a Prognostic Marker.","authors":"Pernille Steen Bække, Ole De Backer, Troels Højsgaard Jørgensen","doi":"10.1002/ccd.31275","DOIUrl":"https://doi.org/10.1002/ccd.31275","url":null,"abstract":"","PeriodicalId":9650,"journal":{"name":"Catheterization and Cardiovascular Interventions","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142458774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polymer free biolimus coated stents to treat acute ST-elevation myocardial infarction in Asian patients. 治疗亚洲患者急性ST段抬高型心肌梗死的无聚合物生物利莫司涂层支架。
IF 2.1 3区 医学
Catheterization and Cardiovascular Interventions Pub Date : 2024-10-21 DOI: 10.1002/ccd.31263
Paul J L Ong, Shing Fung Chui, Frankie Chor-Cheung Tam, Quang Tuan Nguyen, Cheng-Ting Tsai, Woong Chol Kang, Amin Arif Nuruddin, Ramesh Singh, Chunhakasem Chotinaiwattarakul, Michael Lee
{"title":"Polymer free biolimus coated stents to treat acute ST-elevation myocardial infarction in Asian patients.","authors":"Paul J L Ong, Shing Fung Chui, Frankie Chor-Cheung Tam, Quang Tuan Nguyen, Cheng-Ting Tsai, Woong Chol Kang, Amin Arif Nuruddin, Ramesh Singh, Chunhakasem Chotinaiwattarakul, Michael Lee","doi":"10.1002/ccd.31263","DOIUrl":"https://doi.org/10.1002/ccd.31263","url":null,"abstract":"<p><strong>Background: </strong>Patients undergoing primary percutaneous coronary intervention (PPCI) for ST-segment-elevation myocardial infarction (STEMI) have a high thrombotic burden and often have a high bleeding risk (HBR). Asian patients have different patterns of thrombotic and bleeding risk from other populations which may be particularly relevant in the setting of PPCI for STEMI.</p><p><strong>Objectives: </strong>To assess the safety and efficacy of the polymer free biolimus coated coronary stent (PF-BCS, BioFreedom<sup>TM</sup>, Biosensors International) in Asian STEMI patients.</p><p><strong>Methods: </strong>Patients with acute STEMI who received at least one PF-BCS were invited to participate after their index procedure. Follow-up was performed at 1, 4, and 12 months. The primary endpoint was the rate of target lesion failure (TLF) at 1 year. A performance goal was derived from the biolimus eluting stent arm of the COMFORTABLE AMI study which was the only prior dedicated study of biolimus eluting stents in patients with STEMI.</p><p><strong>Results: </strong>A total of 914 patients with STEMI were enrolled. Mean patient age was 60 ± 13 years, diabetes was present in 23.2% and 43% were active smokers. According to the ARC definition, 12.4% of the patients were HBR. TLF rate was 2.54% [95% CI: 1.52-3.56], p-value for non-inferiority <0.0001, p-value for superiority = 0.0004). The rate of definite/probable stent thrombosis was 0.44% [95% CI: 0.16-1.16]. There was a trend toward more BARC 3 to 5 bleeding in ARC-HBR patients (3.69% vs 1.46%, HR = 2.74, [95% CI: 0.87-8.62], p = 0.07).</p><p><strong>Conclusions: </strong>In Asian patients undergoing PPCI for STEMI and treated with variable durations of DAPT, the use of a PF-BCS was associated with low rates of TLF and stent thrombosis (NCT03609346).</p>","PeriodicalId":9650,"journal":{"name":"Catheterization and Cardiovascular Interventions","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142458779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of levosimendan in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: The LEVOCEST trial. 左西孟旦对接受经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者的疗效和安全性:LEVOCEST试验。
IF 2.1 3区 医学
Catheterization and Cardiovascular Interventions Pub Date : 2024-10-19 DOI: 10.1002/ccd.31267
Francisco Bosa Ojeda, Corabel Méndez Vargas, Juan Lacalzada Almeida, María M Izquierdo Gómez, Alejandro Jiménez Sosa, Consuelo Rodríguez Jiménez, Alejandro Sánchez-Grande Flecha, Marta Bosa Santana, Geoffrey Yanes Bowden
{"title":"Efficacy and safety of levosimendan in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: The LEVOCEST trial.","authors":"Francisco Bosa Ojeda, Corabel Méndez Vargas, Juan Lacalzada Almeida, María M Izquierdo Gómez, Alejandro Jiménez Sosa, Consuelo Rodríguez Jiménez, Alejandro Sánchez-Grande Flecha, Marta Bosa Santana, Geoffrey Yanes Bowden","doi":"10.1002/ccd.31267","DOIUrl":"https://doi.org/10.1002/ccd.31267","url":null,"abstract":"<p><strong>Background: </strong>Primary angioplasty is the standard procedure for patients with ST-segment elevation myocardial infarction (STEMI). However, myocardial reperfusion results in additional cell damage. Levosimendan, due to its pleiotropic effects, may be a therapeutic alternative to prevent this damage. The objective of this study was to evaluate whether this drug can reduce infarct size in patients with STEMI.</p><p><strong>Methods: </strong>Patients were randomized to receive a 24-h infusion of either levosimendan (0.1 μg/kg/min) or placebo after the primary angioplasty. The main objective was to assess the size of the infarct by cardiac resonance at 30 days and 6 months after the event. Other variables such as left ventricular ejection fraction (LVEF) and adverse ventricular remodeling (AVR) were assessed by speckle-tracking echocardiography and magnetic resonance. Major adverse cardiovascular events (MACE) were also collected.</p><p><strong>Results: </strong>157 patients were analysed (levosimendan, n = 79; placebo, n = 78). We found that after 6 months, patients treated with levosimendan had a greater reduction in infarct size (13.19% ± 9.5% vs.11.79% ± 9%, p = 0.001), compared with those in the placebo group (13.35% ± 7.1% vs. 13.43% ± 7.8%, p = 0.38). There were no significant differences in MACE between both groups.</p><p><strong>Conclusions: </strong>Levosimendan is a safe and effective therapeutic option for reducing infarct size in patients with STEMI.</p>","PeriodicalId":9650,"journal":{"name":"Catheterization and Cardiovascular Interventions","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142458773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信